Argan
117 hedge funds and large institutions have $365M invested in Argan in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 48 reducing their positions, and 15 closing their positions.
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
1% more funds holding
Funds holding: 116 → 117 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.86% less ownership
Funds ownership: 82.83% → 81.97% (-0.86%)
17% less capital invested
Capital invested by funds: $439M → $365M (-$74M)
33% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 48
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $405K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.87M |
| 2 |
AC
AltraVue Capital
Bellevue,
Washington
|
-$2.68M |
| 3 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.2M |
| 4 |
Renaissance Technologies
New York
|
-$1.94M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.58M |
AGX Hedge Fund Activity: Q3 2022 in Review
117 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Argan (AGX) for Q3 2022, worth a combined $365M — down 17% from $439M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new AGX positions and 15 closed out — a net gain of 1 holder — while 32 added to existing stakes and 48 trimmed.
The largest buyer was Azarias Capital Management, adding an estimated $1.57M. The largest seller was Goldman Sachs, cutting an estimated $3.87M.
- 117 institutional investors held Argan (AGX) as of Q3 2022, up from 116 in Q2 2022.
- Funds reported $365M of Argan stock for Q3 2022, down 17% quarter-over-quarter.
- 16 funds opened new Argan positions in Q3 2022 and 15 closed out, a net change of +1 holder.
- The largest Argan buyer in Q3 2022 was Azarias Capital Management, an estimated $1.57M added.
- The largest Argan seller in Q3 2022 was Goldman Sachs, an estimated $3.87M sold.
Based on aggregated 13F filings for Q3 2022.